Journal Club 1. Long-term Outcomes After Bladder-preserving Tri-modality Therapy of MIBC 2. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE)

Alle
Rapportraum Urologie U1 ASH
07.00Uhr